JP Stock MarketDetailed Quotes

190A Chordia Therapeutics

Watchlist

254
-22-7.97%

20min DelayMarket Closed Nov 29 15:30 JST

17.30BMarket Cap-8164P/E (Static)

Chordia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Aug 31, 2024

(FY)Aug 31, 2023

(FY)Aug 31, 2022

(FY)Aug 31, 2021

Operating cash flow (Indirect Method)

Cash from operating activities

-465.18%-1.96B

131.21%536.15M

-195.32%-1.72B

-581.78M

Net profit before non-cash adjustment

-908.25%-1.82B

112.71%225.76M

-238.27%-1.78B

---525.21M

Total adjustment of non-cash items

-208.02%-243.67M

259.24%225.58M

-289.85%-141.67M

--74.62M

-Depreciation and amortization

-32.22%4.1M

91.99%6.04M

349.57%3.15M

--700K

-Remuneration paid in stock

----

112.45%24.53M

--11.55M

-Other non-cash items

-212.86%-247.77M

229.64%219.54M

-371.49%-169.34M

--62.37M

Changes in working capital

30.25%110.46M

-57.63%84.81M

252.57%200.16M

---131.19M

-Change in prepaid assets

50.99%-7.81M

-110.17%-15.94M

190.89%156.71M

---172.42M

-Change in payables

23.61%133.99M

139.17%108.4M

12.74%45.33M

--40.21M

-Provision for loans, leases and other losses

-105.41%-15.72M

-308.38%-7.65M

-282.47%-1.87M

--1.03M

Dividends paid (cash flow from operating activities)

Dividends received (cash flow from operating activities)

Interest paid (cash flow from operating activities)

Interest received (cash flow from operating activities)

Tax refund paid

0.00%-2.42M

-27.37%-2.42M

0.00%-1.9M

-1.9M

Other operating cash inflow (outflow)

130.91%23.09M

-37.15%10M

-59.30%15.91M

39.09M

Operating cash flow

-456.29%-1.94B

131.91%543.73M

-212.92%-1.7B

---544.59M

Investing cash flow

Net PPE purchase and sale

-54.76%-537K

96.03%-347K

-565.96%-8.74M

---1.31M

Net intangibles purchase and sale

--0

92.17%-376K

-371.51%-4.8M

---1.02M

Net changes in other investments

-1,075.84%-10.42M

192.71%1.07M

-3,872.41%-1.15M

---29K

Investing cash flow

-3,276.52%-10.96M

102.35%345K

-522.71%-14.7M

---2.36M

Financing cash flow

Net common stock issuance

--1.48B

--0

160.54%3.98B

--1.53B

Net other fund-raising expenses

----

--1K

Financing cash flow

--1.48B

--0

160.54%3.98B

--1.53B

Net cash flow

Beginning cash position

12.79%4.8B

112.94%4.25B

96.05%2B

--1.02B

Current changes in cash

-186.28%-469.41M

-75.89%544.08M

130.53%2.26B

--978.97M

Cash adjustments other than cash changes

-200.00%-1K

200.00%1K

0.00%-1K

---1K

End cash Position

-9.78%4.33B

12.79%4.8B

112.94%4.25B

--2B

Free cash flow

-456.86%-1.94B

131.61%543.01M

-214.06%-1.72B

---546.92M

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Aug 31, 2024	(FY)Aug 31, 2023	(FY)Aug 31, 2022	(FY)Aug 31, 2021
Operating cash flow (Indirect Method)
Cash from operating activities	-465.18%-1.96B	131.21%536.15M	-195.32%-1.72B	-581.78M
Net profit before non-cash adjustment	-908.25%-1.82B	112.71%225.76M	-238.27%-1.78B	---525.21M
Total adjustment of non-cash items	-208.02%-243.67M	259.24%225.58M	-289.85%-141.67M	--74.62M
-Depreciation and amortization	-32.22%4.1M	91.99%6.04M	349.57%3.15M	--700K
-Remuneration paid in stock	----	----	112.45%24.53M	--11.55M
-Other non-cash items	-212.86%-247.77M	229.64%219.54M	-371.49%-169.34M	--62.37M
Changes in working capital	30.25%110.46M	-57.63%84.81M	252.57%200.16M	---131.19M
-Change in prepaid assets	50.99%-7.81M	-110.17%-15.94M	190.89%156.71M	---172.42M
-Change in payables	23.61%133.99M	139.17%108.4M	12.74%45.33M	--40.21M
-Provision for loans, leases and other losses	-105.41%-15.72M	-308.38%-7.65M	-282.47%-1.87M	--1.03M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
Tax refund paid	0.00%-2.42M	-27.37%-2.42M	0.00%-1.9M	-1.9M
Other operating cash inflow (outflow)	130.91%23.09M	-37.15%10M	-59.30%15.91M	39.09M
Operating cash flow	-456.29%-1.94B	131.91%543.73M	-212.92%-1.7B	---544.59M
Investing cash flow
Net PPE purchase and sale	-54.76%-537K	96.03%-347K	-565.96%-8.74M	---1.31M
Net intangibles purchase and sale	--0	92.17%-376K	-371.51%-4.8M	---1.02M
Net changes in other investments	-1,075.84%-10.42M	192.71%1.07M	-3,872.41%-1.15M	---29K
Investing cash flow	-3,276.52%-10.96M	102.35%345K	-522.71%-14.7M	---2.36M
Financing cash flow
Net common stock issuance	--1.48B	--0	160.54%3.98B	--1.53B
Net other fund-raising expenses	----	----	----	--1K
Financing cash flow	--1.48B	--0	160.54%3.98B	--1.53B
Net cash flow
Beginning cash position	12.79%4.8B	112.94%4.25B	96.05%2B	--1.02B
Current changes in cash	-186.28%-469.41M	-75.89%544.08M	130.53%2.26B	--978.97M
Cash adjustments other than cash changes	-200.00%-1K	200.00%1K	0.00%-1K	---1K
End cash Position	-9.78%4.33B	12.79%4.8B	112.94%4.25B	--2B
Free cash flow	-456.86%-1.94B	131.61%543.01M	-214.06%-1.72B	---546.92M
Currency Unit	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data